SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-015949
Filing Date
2024-04-25
Accepted
2024-04-25 16:45:15
Documents
14
Period of Report
2024-04-24
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 49106
  Complete submission text file 0001493152-24-015949.txt   275043

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE bfri-20240424.xsd EX-101.SCH 4083
3 XBRL DEFINITION FILE bfri-20240424_def.xml EX-101.DEF 27158
4 XBRL LABEL FILE bfri-20240424_lab.xml EX-101.LAB 37577
5 XBRL PRESENTATION FILE bfri-20240424_pre.xml EX-101.PRE 25778
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6924
Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325
Biofrontera Inc. (Filer) CIK: 0001858685 (see all company filings)

IRS No.: 473765675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40943 | Film No.: 24877138
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)